![](/img/cover-not-exists.png)
Phase I trial and pharmacokinetic study of a new orally administered platinum anticancer drug JM 216 [AF-bis(acetato)-B-ammine-CD-dichloro-E-cyclohexylamine platinum(IV)]
Judson, I, McKeage, M, Mistry, P, Ward, J, Murrer, B, Harrap, KVolume:
29
Year:
1993
Language:
english
DOI:
10.1016/0959-8049(93)91262-J
File:
PDF, 173 KB
english, 1993